Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy. (Q52645997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Hiroaki Senju

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Asuka Kumagai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Yoichi Nakamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Katsumi Nakatomi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Shota Fukami

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Kengo Shiraishi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Yuka Harada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Mitsuhiro Nakamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Haruki Okamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Hiroshi Mukae

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

English

0 references

publication date

9 March 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Biological Sciences

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

331-340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

Phase 1 clinical trial using mbIL21 ex-vivo expanded donor-derived NK cells after haploidentical transplantation

20 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Natural killer cell memory in infection, inflammation and cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Immune checkpoint blockade: a common denominator approach to cancer therapy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantation

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Expansion of highly cytotoxic human natural killer cells for cancer cell therapy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

IL-1, IL-18, and IL-33 families of cytokines

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

IL-18-induced CD83+CCR7+ NK helper cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Helper role of NK cells during the induction of anticancer responses by dendritic cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Toll-like receptor signalling

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

A potential role for interleukin-15 in the regulation of human natural killer cell survival

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Multiple effects of IL-21 on human NK cells in ex vivo expansion.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5859478

A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells

13 August 2018

1 reference

12 December 2020

IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity

1 reference

12 December 2020

Phenotype and function of a CD56+ peripheral blood monocyte

1 reference

12 December 2020

Interleukin-21 differentially affects human natural killer cell subsets

1 reference

12 December 2020

Involvement of CD56brightCD11c+ Cells in IL-18-Mediated Expansion of Human T Cells

1 reference

12 December 2020

Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors

1 reference

12 December 2020

Identifiers

DOI

10.7150/IJBS.22809

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

release_q6evpuvzbrgrdfyskydzkcc3qe

20 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q6evpuvzbrgrdfyskydzkcc3qe

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

29559850

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29559850%20AND%20SRC:MED&resulttype=core&format=json